Cargando…
High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty pat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452386/ https://www.ncbi.nlm.nih.gov/pubmed/28569169 http://dx.doi.org/10.1186/s13014-017-0831-y |
_version_ | 1783240408032083968 |
---|---|
author | Kong, Xiang-quan Dong, Ya-ping Wu, Jun-xin He, Jun-yan Le, Yu-yin Du, Kai-xin Peng, Qing-qin Li, Jin-luan |
author_facet | Kong, Xiang-quan Dong, Ya-ping Wu, Jun-xin He, Jun-yan Le, Yu-yin Du, Kai-xin Peng, Qing-qin Li, Jin-luan |
author_sort | Kong, Xiang-quan |
collection | PubMed |
description | BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty patients diagnosed with HCC having a tumor thrombus between May 2006 and April 2014 were enrolled in this study. Age, gender, clinical characteristics, laboratory findings, Child-Pugh classification, performance status (ECOG), types of tumor thrombi, radiotherapy method, biologically effective dose (BED), and primary treatment method were analyzed to identify the prognostic factors associated with the overall survival (OS) rates. Statistical analyses were performed using SPSS version 19.0. RESULTS: The median follow-up duration was 24 months (range 6–90). The 1-, 3-, and 5-year OS rates of the patients were 77.6%, 37.6%, and 18.8%, respectively. On univariate analysis, gender, radiotherapy method, BED, types of tumor thrombi, Child-Pugh classification, ECOG, and total bilirubin were associated with OS (P < 0.001, P = 0.001, P = 0.016, P = 0.003, P < 0.001, P < 0.001, P = 0.039, respectively). The prognostic factors for OS in multi-variate analyses were gender (P < 0.001), BED (P = 0.044), Child Pugh classification (P = 0.020), performance status (ECOG) (P = 0.004), and types of tumor thrombi (P = 0.001). The median OS for the high-BED group was better than that for the low-BED groups (42 months vs. 19 months, P = 0.016). CONCLUSIONS: Gender, BED, performance status (ECOG), Child-Pugh classification, and types of tumor thrombi seemed to affect OS, and a stepwise decrease in survival was observed with the types of tumor thrombi ranging from I to IV. High-BED palliative radiotherapy might improve the long-term outcomes for patients with HCC having a tumor thrombus. |
format | Online Article Text |
id | pubmed-5452386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54523862017-06-01 High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study Kong, Xiang-quan Dong, Ya-ping Wu, Jun-xin He, Jun-yan Le, Yu-yin Du, Kai-xin Peng, Qing-qin Li, Jin-luan Radiat Oncol Research BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty patients diagnosed with HCC having a tumor thrombus between May 2006 and April 2014 were enrolled in this study. Age, gender, clinical characteristics, laboratory findings, Child-Pugh classification, performance status (ECOG), types of tumor thrombi, radiotherapy method, biologically effective dose (BED), and primary treatment method were analyzed to identify the prognostic factors associated with the overall survival (OS) rates. Statistical analyses were performed using SPSS version 19.0. RESULTS: The median follow-up duration was 24 months (range 6–90). The 1-, 3-, and 5-year OS rates of the patients were 77.6%, 37.6%, and 18.8%, respectively. On univariate analysis, gender, radiotherapy method, BED, types of tumor thrombi, Child-Pugh classification, ECOG, and total bilirubin were associated with OS (P < 0.001, P = 0.001, P = 0.016, P = 0.003, P < 0.001, P < 0.001, P = 0.039, respectively). The prognostic factors for OS in multi-variate analyses were gender (P < 0.001), BED (P = 0.044), Child Pugh classification (P = 0.020), performance status (ECOG) (P = 0.004), and types of tumor thrombi (P = 0.001). The median OS for the high-BED group was better than that for the low-BED groups (42 months vs. 19 months, P = 0.016). CONCLUSIONS: Gender, BED, performance status (ECOG), Child-Pugh classification, and types of tumor thrombi seemed to affect OS, and a stepwise decrease in survival was observed with the types of tumor thrombi ranging from I to IV. High-BED palliative radiotherapy might improve the long-term outcomes for patients with HCC having a tumor thrombus. BioMed Central 2017-05-31 /pmc/articles/PMC5452386/ /pubmed/28569169 http://dx.doi.org/10.1186/s13014-017-0831-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kong, Xiang-quan Dong, Ya-ping Wu, Jun-xin He, Jun-yan Le, Yu-yin Du, Kai-xin Peng, Qing-qin Li, Jin-luan High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title | High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title_full | High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title_fullStr | High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title_full_unstemmed | High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title_short | High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
title_sort | high-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452386/ https://www.ncbi.nlm.nih.gov/pubmed/28569169 http://dx.doi.org/10.1186/s13014-017-0831-y |
work_keys_str_mv | AT kongxiangquan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT dongyaping highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT wujunxin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT hejunyan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT leyuyin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT dukaixin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT pengqingqin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy AT lijinluan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy |